Reproductive BioMedicine Online
Volume 21, Issue 3 , Pages 304-311, September 2010

New target cells of the immunomodulatory effects of progesterone

  • Dobroslav Kyurkchiev

      Affiliations

    • Laboratory of Clinical Immunology, University Hospital ‘St. Ivan Rilski’, Medical University Sofia, 15 Acad. Ivan Geshov, 1431 Sofia, Bulgaria
    • Corresponding Author InformationCorresponding author.
    • ,
  • Ekaterina Ivanova-Todorova

      Affiliations

    • Laboratory of Clinical Immunology, University Hospital ‘St. Ivan Rilski’, Medical University Sofia, 15 Acad. Ivan Geshov, 1431 Sofia, Bulgaria
    • ,
  • Stanimir Dobrev Kyurkchiev

      Affiliations

    • Department of Molecular Immunology, Institute of Biology and Immunology of Reproduction, Bulgarian Academy of Sciences, 73 Tzarigradsko Shosse, 1113 Sofia, Bulgaria

Received 15 December 2009; received in revised form 1 April 2010; accepted 7 April 2010. published online 20 July 2010.

Declaration: The authors report no financial or commercial conflicts of interest.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Dr Dobroslav Kyurkchiev graduated from the Medical University in Sofia, Bulgaria with his MD and in 2003 he gained his PhD in clinical immunology. Since 2004, he has been working in the Department of Clinical Laboratory and Clinical Immunology, Medical University, Sofia. Dr Kyurkchiev has successfully researched the participation of the immune cells in the pathogenesis of the antiphospholipid syndrome and particularly the cellular immune response against β2-glycoprotein I. Currently he is researching the effect of reproductive steroid hormones on cells that are actively engaged in the control of the immune response in pregnancy.

PII: S1472-6483(10)00226-9

doi:10.1016/j.rbmo.2010.04.014

Reproductive BioMedicine Online
Volume 21, Issue 3 , Pages 304-311, September 2010

Article Tools